Page last updated: 2024-10-24

chlorpheniramine and Hemophilia A

chlorpheniramine has been researched along with Hemophilia A in 2 studies

Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.

Hemophilia A: The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.

Research Excerpts

ExcerptRelevanceReference
"To report a case of acquired hemophilia with a high-titer factor VIII inhibitor associated with the use of acetaminophen and chlorpheniramine in combination."1.32Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine. ( De Maria, S; Famularo, G; Minisola, G; Nicotra, GC, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Famularo, G1
De Maria, S1
Minisola, G1
Nicotra, GC1
Mason, DY1
Ingram, GI1

Other Studies

2 other studies available for chlorpheniramine and Hemophilia A

ArticleYear
Severe acquired hemophilia with factor VIII inhibition associated with acetaminophen and chlorpheniramine.
    The Annals of pharmacotherapy, 2004, Volume: 38, Issue:9

    Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Blood Coagulation Factors; Chlorph

2004
Management of the hereditary coagulation disorders.
    Seminars in hematology, 1971, Volume: 8, Issue:2

    Topics: Antifibrinolytic Agents; Blood Coagulation Disorders; Blood Coagulation Factors; Cerebral Hemorrhage

1971